{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:30:15Z","timestamp":1791329415824,"version":"4.3.1"},"reference-count":118,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,4]],"date-time":"2012-06-04T00:00:00Z","timestamp":1338768000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0037366","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T07:29:36Z","timestamp":1338881376000},"page":"e37366","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion"],"prefix":"10.1371","volume":"7","author":[{"given":"Nirmalya","family":"Dey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falguni","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Ghosh-Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandi Charan","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipen J.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balakuntalam S.","family":"Kasinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna E.","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam Ghosh","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,6,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.urolonc.2007.03.006","article-title":"Kidney cancer: past, present, and future.","volume":"25","author":"AC Novick","year":"2007","journal-title":"Urol Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncponc0479","article-title":"Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?","volume":"3","author":"O Rouviere","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"ref3","article-title":"Chemotherapeutic strategies for renal cell carcinoma.","volume":"x","author":"MI Milowsky","year":"2003","journal-title":"Urol Clin North Am 30: 601\u2013609,"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome.","volume":"2","author":"Kaelin WG Jr","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/cncr.24232","article-title":"Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein.","volume":"115","author":"Kaelin WG Jr","year":"2009","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ncb1699","article-title":"VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400.","volume":"10","author":"AP Young","year":"2008","journal-title":"Nat Cell Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","article-title":"The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer.","volume":"8","author":"Kaelin WG Jr","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function.","volume":"116","author":"DP Bartel","year":"2004","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions.","volume":"136","author":"DP Bartel","year":"2009","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1126\/science.319.5871.1782","article-title":"MicroRNAs make big impression in disease after disease.","volume":"319","author":"J Couzin","year":"2008","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene.","volume":"435","author":"L He","year":"2005","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs.","volume":"79","author":"MR Fabian","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.molcel.2011.07.024","article-title":"Alternative miRNA Biogenesis Pathways and the Interpretation of Core miRNA Pathway Mutants.","volume":"43","author":"JS Yang","year":"2011","journal-title":"Mol Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.urology.2009.10.033","article-title":"Identification of a microRNA panel for clear-cell kidney cancer.","volume":"75","author":"D Juan","year":"2010","journal-title":"Urology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3892\/ijo_00000318","article-title":"MicroRNA profiling of human kidney cancer subtypes.","volume":"35","author":"D Petillo","year":"2009","journal-title":"Int J Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/path.2437","article-title":"Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.","volume":"216","author":"C Nakada","year":"2008","journal-title":"J Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ejso.2009.04.010","article-title":"Microarray analysis of microRNA expression in renal clear cell carcinoma.","volume":"35","author":"Y Huang","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1101\/gr.098046.109","article-title":"Reprogramming of miRNA networks in cancer and leukemia.","volume":"20","author":"S Volinia","year":"2010","journal-title":"Genome Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/PDM.0b013e3181efe2a9","article-title":"Molecular classification of adult renal epithelial neoplasms using microRNA expression and virtual karyotyping.","volume":"20","author":"MP Powers","year":"2011","journal-title":"Diagn Mol Pathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.molcel.2010.07.011","article-title":"Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha.","volume":"39","author":"BN Davis","year":"2011","journal-title":"Mol Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/nar\/gkq056","article-title":"Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells.","volume":"38","author":"R Zhou","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/24.3.377","article-title":"Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma.","volume":"24","author":"M Oya","year":"2003","journal-title":"Carcinogenesis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1038\/sj.onc.1204525","article-title":"Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.","volume":"20","author":"M Oya","year":"2001","journal-title":"Oncogene"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"18934","DOI":"10.1074\/jbc.M101103200","article-title":"Akt stimulates the transactivation potential of the RelA\/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.","volume":"276","author":"LV Madrid","year":"2001","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"25586","DOI":"10.1074\/jbc.M110.208066","article-title":"MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes.","volume":"286","author":"N Dey","year":"2011","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.","volume":"4","author":"MS Ebert","year":"2007","journal-title":"Nat Methods"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc1819","article-title":"Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.","volume":"6","author":"M Cully","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","article-title":"Tenets of PTEN tumor suppression.","volume":"133","author":"L Salmena","year":"2008","journal-title":"Cell"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/cncr.25402","article-title":"The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases.","volume":"117","author":"T Abou Youssif","year":"2010","journal-title":"Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1053\/j.gastro.2006.02.057","article-title":"Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.","volume":"130","author":"F Meng","year":"2006","journal-title":"Gastroenterology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.","volume":"273","author":"T Maehama","year":"1998","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway.","volume":"96","author":"LC Cantley","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1128\/MCB.18.4.1802","article-title":"Protein kinase B activation and lamellipodium formation are independent phosphoinositide 3-kinase-mediated events differentially regulated by endogenous Ras.","volume":"18","author":"DH van Weering","year":"1998","journal-title":"Mol Cell Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gad.1314605","article-title":"Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.","volume":"19","author":"BD Manning","year":"2005","journal-title":"Genes Dev"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway.","volume":"10","author":"BD Manning","year":"2002","journal-title":"Mol Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.","volume":"13","author":"AR Tee","year":"2003","journal-title":"Curr Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.","volume":"133","author":"F Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers.","volume":"435","author":"J Lu","year":"2005","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","article-title":"miR-21-mediated tumor growth.","volume":"26","author":"ML Si","year":"2007","journal-title":"Oncogene"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer.","volume":"65","author":"MV Iorio","year":"2005","journal-title":"Cancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","article-title":"MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.","volume":"65","author":"JA Chan","year":"2005","journal-title":"Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.299.4.425","article-title":"MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.","volume":"299","author":"AJ Schetter","year":"2008","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.","volume":"9","author":"N Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ijc.22800","article-title":"MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma.","volume":"121","author":"CH Lawrie","year":"2007","journal-title":"Int J Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1182\/blood-2007-06-096784","article-title":"MicroRNA expression profiling in classic Hodgkin lymphoma.","volume":"111","author":"A Navarro","year":"2008","journal-title":"Blood"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ccr.2010.08.013","article-title":"Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.","volume":"18","author":"ME Hatley","year":"2010","journal-title":"Cancer Cell"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature09284","article-title":"OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.","volume":"467","author":"PP Medina","year":"2010","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1158\/0008-5472.CAN-08-1305","article-title":"MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells.","volume":"68","author":"T Papagiannakopoulos","year":"2008","journal-title":"Cancer Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","article-title":"miR-21: a small multi-faceted RNA.","volume":"13","author":"AM Krichevsky","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/MNH.0b013e32832c9da2","article-title":"MicroRNAs and the kidney: coming of age.","volume":"18","author":"S Saal","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"14339","DOI":"10.1073\/pnas.0912701107","article-title":"Identification of a microRNA signature of renal ischemia reperfusion injury.","volume":"107","author":"JG Godwin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajpath.2011.04.021","article-title":"miR-21 and miR-214 are consistently modulated during renal injury in rodent models.","volume":"179","author":"L Denby","year":"2011","journal-title":"Am J Pathol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"F793","DOI":"10.1152\/ajprenal.00273.2011","article-title":"Identification of a microRNA signature in renal fibrosis: role of miR-21.","volume":"301","author":"A Zarjou","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2215\/CJN.00520109","article-title":"MicroRNAs and their role in progressive kidney diseases.","volume":"4","author":"M Kato","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1741-7015-8-64","article-title":"The VHL-dependent regulation of microRNAs in renal cancer.","volume":"8","author":"CS Neal","year":"2010","journal-title":"BMC Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00432-009-0726-x","article-title":"Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues.","volume":"136","author":"Z Yi","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-05-3074","article-title":"Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.","volume":"66","author":"RE Banks","year":"2006","journal-title":"Cancer Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","article-title":"Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.","volume":"14","author":"ML Nickerson","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1158\/1078-0432.CCR-07-1753","article-title":"Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.","volume":"14","author":"KM Smits","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1158\/1078-0432.CCR-09-3022","article-title":"The efficacy of the novel dual PI3-kinase\/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma.","volume":"16","author":"DC Cho","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10555-007-9090-y","article-title":"Renal cell carcinoma bone metastasis\u2013elucidating the molecular targets.","volume":"26","author":"K Weber","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature07086","article-title":"SMAD proteins control DROSHA-mediated microRNA maturation.","volume":"454","author":"BN Davis","year":"2008","journal-title":"Nature"},{"key":"ref63","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2002165","article-title":"Structural basis for activation and inhibition of class I phosphoinositide 3-kinases.","volume":"4","author":"O Vadas","year":"2011","journal-title":"Sci Signal"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10555-010-9261-0","article-title":"The phosphatidyl inositol 3-kinase\/AKT signaling pathway in breast cancer.","volume":"29","author":"CA Castaneda","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrc3037","article-title":"PTEN loss in the continuum of common cancers, rare syndromes and mouse models.","volume":"11","author":"MC Hollander","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/sj.onc.1201855","article-title":"Point mutation and homozygous deletion of PTEN\/MMAC1 in primary bladder cancers.","volume":"16","author":"P Cairns","year":"1998","journal-title":"Oncogene"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/jso.10302","article-title":"Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth.","volume":"84","author":"J Shin Lee","year":"2003","journal-title":"J Surg Oncol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-008-0227-7","article-title":"Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth.","volume":"118","author":"T Ghosh-Choudhury","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1038\/onc.2008.242","article-title":"Post-translational regulation of PTEN.","volume":"27","author":"X Wang","year":"2008","journal-title":"Oncogene"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/gcc.20887","article-title":"Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.","volume":"50","author":"KL Bennett","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"ref72","first-page":"pe39","article-title":"Posttranscriptional regulation of PTEN dosage by noncoding RNAs.","volume":"3","author":"L He","year":"2010","journal-title":"Sci Signal"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"ra29","DOI":"10.1126\/scisignal.2000594","article-title":"Identification of the miR-106 b\u223c25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.","volume":"3","author":"L Poliseno","year":"2010","journal-title":"Sci Signal"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.1191531","article-title":"Molecular biology. Paring miRNAs through pairing.","volume":"328","author":"AE Pasquinelli","year":"2010","journal-title":"Science"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.4161\/cc.9.22.13936","article-title":"Both lipid- and protein-phosphatase activities of PTEN contribute to the p53-PTEN anti-invasion pathway.","volume":"9","author":"JS Poon","year":"2010","journal-title":"Cell Cycle"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1126\/science.280.5369.1614","article-title":"Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.","volume":"280","author":"M Tamura","year":"1998","journal-title":"Science"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"15258","DOI":"10.1074\/jbc.M314328200","article-title":"Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase.","volume":"279","author":"L Mahimainathan","year":"2004","journal-title":"J Biol Chem"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1158\/0008-5472.CAN-07-1182","article-title":"The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.","volume":"68","author":"N Dey","year":"2008","journal-title":"Cancer Res"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1083\/jcb.143.5.1375","article-title":"Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.","volume":"143","author":"J Gu","year":"1998","journal-title":"J Cell Biol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/onc.2009.384","article-title":"Davidson L, Maccario H, Perera NM, Yang X, Spinelli L, et al. Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN.","volume":"29","journal-title":"Oncogene"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.1068094","article-title":"Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt\/PKB.","volume":"295","author":"H Stocker","year":"2002","journal-title":"Science"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1158\/1078-0432.CCR-06-1609","article-title":"PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer.","volume":"13","author":"G Perez-Tenorio","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ydbio.2004.06.008","article-title":"PTENless means more.","volume":"273","author":"B Stiles","year":"2004","journal-title":"Dev Biol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0092-8674(00)81237-4","article-title":"Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.","volume":"85","author":"K Nakayama","year":"1996","journal-title":"Cell"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/84879","article-title":"Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.","volume":"27","author":"A Di Cristofano","year":"2001","journal-title":"Nat Genet"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1158\/1078-0432.CCR-09-0260","article-title":"Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.","volume":"16","author":"C Dahinden","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.","volume":"110","author":"K Hara","year":"2002","journal-title":"Cell"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.","volume":"10","author":"R Loewith","year":"2002","journal-title":"Mol Cell"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.","volume":"14","author":"DD Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism.","volume":"124","author":"S Wullschleger","year":"2006","journal-title":"Cell"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing.","volume":"12","author":"R Zoncu","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex.","volume":"307","author":"DD Sarbassov","year":"2005","journal-title":"Science"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","article-title":"Regulation of translation initiation in eukaryotes: mechanisms and biological targets.","volume":"136","author":"N Sonenberg","year":"2009","journal-title":"Cell"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream.","volume":"129","author":"BD Manning","year":"2007","journal-title":"Cell"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"31861","DOI":"10.1074\/jbc.M801546200","article-title":"Isolation of hyperactive mutants of mammalian target of rapamycin.","volume":"283","author":"Y Ohne","year":"2008","journal-title":"J Biol Chem"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"10998","DOI":"10.1074\/jbc.M110.195016","article-title":"Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate.","volume":"286","author":"X Gan","year":"2011","journal-title":"J Biol Chem"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cell.2011.02.014","article-title":"Activation of mTORC2 by association with the ribosome.","volume":"144","author":"V Zinzalla","year":"2011","journal-title":"Cell"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.","volume":"6","author":"E Jacinto","year":"2004","journal-title":"Nat Cell Biol"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1038\/onc.2008.137","article-title":"Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins.","volume":"27","author":"L Liu","year":"2008","journal-title":"Oncogene"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1038\/sj.onc.1209691","article-title":"Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.","volume":"25","author":"L Liu","year":"2006","journal-title":"Oncogene"},{"key":"ref101","first-page":"917","article-title":"Rapamycin is an effective inhibitor of human renal cancer metastasis.","volume":"63","author":"FL Luan","year":"2003","journal-title":"Kidney Int"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i1.10","article-title":"mTOR signaling in cancer cell motility and tumor metastasis.","volume":"20","author":"H Zhou","year":"2010","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1200\/JCO.2004.08.185","article-title":"Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma.","volume":"22","author":"MB Atkins","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1002\/cncr.25219","article-title":"Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors.","volume":"116","author":"RJ Motzer","year":"2010","journal-title":"Cancer"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.","volume":"372","author":"RJ Motzer","year":"2008","journal-title":"Lancet"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2146\/news090037","article-title":"New oral treatment for kidney cancer approved.","volume":"66","author":"K Traynor","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1\u20132 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins.","volume":"166","author":"LS Harrington","year":"2004","journal-title":"J Cell Biol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","article-title":"Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies.","volume":"14","author":"OJ Shah","year":"2004","journal-title":"Curr Biol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1371\/journal.pmed.0050008","article-title":"Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.","volume":"5","author":"TF Cloughesy","year":"2008","journal-title":"PLoS Med"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1074\/jbc.M611569200","article-title":"NAD(P)H oxidases regulate HIF-2alpha protein expression.","volume":"282","author":"K Block","year":"2007","journal-title":"J Biol Chem"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"11314","DOI":"10.1074\/jbc.M110.193714","article-title":"Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.","volume":"286","author":"CC Mandal","year":"2011","journal-title":"J Biol Chem"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1172\/JCI1044","article-title":"Association and direct activation of signal transducer and activator of transcription1alpha by platelet-derived growth factor receptor.","volume":"101","author":"GG Choudhury","year":"1998","journal-title":"J Clin Invest"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cellsig.2007.10.027","article-title":"Raptor-rictor axis in TGFbeta-induced protein synthesis.","volume":"20","author":"F Das","year":"2008","journal-title":"Cell Signal"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jcp.22186","article-title":"PRAS40 acts as a nodal regulator of high glucose-induced TORC1 activation in glomerular mesangial cell hypertrophy.","volume":"225","author":"N Dey","year":"2010","journal-title":"J Cell Physiol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1096\/fj.08-109488","article-title":"Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B.","volume":"22","author":"B Venkatesan","year":"2008","journal-title":"FASEB J"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cellsig.2009.12.010","article-title":"Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth.","volume":"22","author":"N Ghosh-Choudhury","year":"2010","journal-title":"Cell Signal"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"27790","DOI":"10.1074\/jbc.M109.028860","article-title":"TSC2 deficiency increases PTEN via HIF1alpha.","volume":"284","author":"L Mahimainathan","year":"2009","journal-title":"J Biol Chem"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2337\/db05-1326","article-title":"Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN.","volume":"55","author":"L Mahimainathan","year":"2006","journal-title":"Diabetes"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0037366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T23:29:45Z","timestamp":1588980585000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0037366"}},"subtitle":[],"editor":[{"given":"Soumitro","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,4]]},"references-count":118,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0037366","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,4]]}}}